Valuation : Biogen Inc.

Market Cap 32.63B 28.1B 26.4B 24.13B 45.15B 3,083B 45.3B 312B 121B 1,580B 123B 120B 5,097B P/E 2026 *
38.1x
P/E 2027 * 19.8x
Enterprise Value 37.57B 32.35B 30.39B 27.78B 51.98B 3,550B 52.16B 359B 139B 1,819B 141B 138B 5,868B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.29x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.64%
1 week+1.07%
Current month+1.93%
1 month+5.94%
3 months+12.41%
6 months+16.26%
Current year+25.48%
1 week 213.58
Extreme 213.58
225.8
1 month 201
Extreme 201
225.8
Current year 160.36
Extreme 160.3645
225.8
1 year 135.39
Extreme 135.39
225.8
3 years 110.04
Extreme 110.035
269.43
5 years 110.04
Extreme 110.035
332.87
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

General Counsel

7,405 0.0050%
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%+1.07%+57.80%-17.34% 32.63B
-1.87%+4.22%+45.93%-0.47% 82.65B
-0.57%+1.27%-17.24%-34.99% 60.24B
-2.23%+5.48%+499.46%+29.31% 58.11B
-2.03%-2.62%-7.46%+27.87% 49.68B
-4.58%-2.73%+2.93%+157.71% 46.66B
-0.98%+1.91%+48.35%+95.93% 25.69B
-0.19%-4.74%+2.30%+196.81% 22.73B
-1.13%-2.45%+65.99%+110.75% 16.51B
+1.94%-9.84%-19.78%+771.20% 14.92B
Average -1.33%-0.83%+67.83%+133.68% 40.98B
Weighted average by Cap. -1.72%+0.49%+86.67%+68.33%

Financials

2026 *2027 *
Net sales 10.44B 8.99B 8.45B 7.72B 14.45B 987B 14.5B 99.89B 38.73B 506B 39.22B 38.36B 1,632B 10.66B 9.18B 8.62B 7.88B 14.74B 1,007B 14.8B 102B 39.51B 516B 40.01B 39.14B 1,665B
Net income 964M 830M 780M 713M 1.33B 91.07B 1.34B 9.22B 3.57B 46.67B 3.62B 3.54B 151B 1.86B 1.6B 1.5B 1.37B 2.57B 175B 2.58B 17.75B 6.88B 89.85B 6.97B 6.81B 290B
Net Debt 4.94B 4.25B 3.99B 3.65B 6.83B 466B 6.85B 47.22B 18.3B 239B 18.54B 18.13B 771B 2.42B 2.08B 1.96B 1.79B 3.35B 229B 3.36B 23.15B 8.97B 117B 9.09B 8.89B 378B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
04/09/26 US$220.83 -1.64% 465,108
03/09/26 US$224.51 +0.83% 550,745
02/09/26 US$222.67 +3.07% 1,268,282
01/09/26 US$216.04 -0.28% 785,496
31/08/26 US$216.65 -0.85% 831,004
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
220.83USD
Average target price
236.87USD
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock